( October 13, 2026, 2:27 PM EDT) -- BOSTON — The First Circuit U.S. Court of Appeals affirmed the dismissal of a woman's wrongful death lawsuit against the manufacturer of the migraine drug Aimovig on federal preemption grounds but ruled that a Massachusetts federal judge erred in denying the woman an opportunity to amend her complaint to allege that newly acquired scientific information permitted the manufacturer to strengthen the drug's warnings....